Maarten de
Château
Member of the Board
Born
1963
Education
Medical degree and PhD from Lund University.
Experience
More than 15 years of experience from roles in clinical drug development and business development at Sanofi, Sobi and Camurus. Prior to that, he worked as a stock analyst.
Current assigments
Chairman of the Board of Atrogi AB, Board member of Targinta AB, Beactica Therapeutics AB, Cavis Technologies AB, Cordivest AB, Chateau Holding AB, Buzzard Pharmaceuticals AB, MetaCurUm Biotech AB and Amarna Holding BV. CEO of Sixera Pharma AB, Cordivest AB, Buzzard Pharmaceuticals AB and MetaCurUm Biotech AB.
Previous Assignments
Member of the Board of OxTheraB, Addbio AB, Gesynta Pharma AB, Evident Life Försäkring AB.
Not independent of the Company and its management but independent of major shareholders.
